The neurobiology of bipolar II disorder

Bipolar II Disorder: Modelling, Measuring and Managing, Second Edition

Volumn , Issue , 2012, Pages 89-99

  Bora, Emre ^a   Pantelis, Christos ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84889094317     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9781139003315.010     Document Type: Chapter

References (67)

1. Altshuler, L. L., Curran, J. G., Hauser, P., Mintz, J., Denicof, K. and Post, R. (1995). T2 hyperintensities in bipolar disorder: magnetic resonance imaging comparison and literature meta-analysis, American Journal of Psychiatry, 152, 1139–1144.
2. Arts, B., Jabben, N., Krabbendam, L. and Van Os, J., (2008). Meta-analyses of cognitive functioning in euthymic bipolar patients and their i rst-degree relatives. Psychological Medicine, 38, 771–785.
3. Berns, G. S., Martin, M. and Proper, S. M. (2002). Limbic hyperreactivity in bipolar II disorder. American Journal of Psychiatry, 159, 304–306.
4. Beyer, J. L., Young, R., Kuchibhatla, M. and Krishnan, K. R. (2009). Hyperintense MRI lesions in bipolar disorder: a metaanalysis and review. International Review of Psychiatry, 21, 394–409.
5. Bora, E. and Pantelis, C. (2011). Structural trait markers of bipolar disorder: disruption of white matter integrity and localized gray matter abnormalities in anterior frontolimbic regions. Biological Psychiatry, 69, 299–300.
6. Bora, E., Y ücel, M. and Pantelis, C. (2009). Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological dei cits in euthymic patients and their i rst-degree relatives. Journal of Affective Disorders, 113, 1–20.
7. Bora, E., Y ücel, M. and Pantelis, C. (2010a). Cognitive impairment in schizophrenia and af ective psychoses: implications for DSM-V criteria and beyond. Schizophrenia Bulletin, 36, 36–42.
8. Bora, E., Fornito, A., Y ücel, M. and Pantelis, C. (2010b). Voxelwise meta-analysis of gray matter abnormalities in bipolar disorder. Biological Psychiatry, 67, 1097–1105.
9. Bora, E., Yücel, M., Pantelis, C. and Berk, M. (2011). Meta-analytic review of neurocognition in bipolar II disorder. Acta Psychiatrica Scandanivica, 123, 165–174.
10. Brambilla, P., Bellani, M., Yeh, P. H., Soares, J. C. and Tansella, M. (2009). White matter connectivity in bipolar disorder. International Review of Psychiatry, 21, 380–386.
11. Brooks, J. O. 3rd., Bearden, C. E., Hoblyn, J. C., Woodard, S. A. and Ketter, T. A. (2010). Prefrontal and paralimbic metabolic dysregulation related to sustained attention in euthymic older adults with bipolar disorder. Bipolar Disorders, 12, 866–874.
12. Cannon, D. M., Ichise, M., Fromm, S. J. et al. (2006). Serotonin transporter binding in bipolar disorder assessed using [11C] DASB and positron emission tomography. Biological Psychiatry, 60, 207–217.
13. Chen, C. H., Suckling, J., Lennox, B. R., Ooi, C. and Bullmore, E. T. (2011). A quantitative meta-analysis of fMRI studies in bipolar disorder. Bipolar Disorders, 13, 1–15.
14. Chou, Y. H., Wang, S. J., Lin, C. L., Mao, W. C., Lee, S. M. and Liao, M. H. (2010). Decreased brain serotonin transporter binding in the euthymic state of bipolar I but not bipolar II disorder: a SPECT study. Bipolar Disorders, 12, 312–318.
15. Coryell, W., Endicott, J., Reich, T., Andreasen, N. and Keller, M. (1984). A family study of bipolar II disorder. British Journal of Psychiatry, 145, 49–54.
16. Dager, S. R., Friedman, S. D., Parow, A. et al. (2004). Brain metabolic alterations in medication-free patients with bipolar disorder. Archives of General Psychiatry, 61, 450–458.
17. Dittmann, S., Hennig-Fast, K., Gerber, S. et al. (2008). Cognitive functioning in euthymic bipolar I and bipolar II patients. Bipolar Disorders, 10, 877–887.
18. Dubovsky, S. L., h omas, M., Hijazi, A. and Murphy, J. (1994). Intracellular calcium signalling in peripheral cells of patients with bipolar af ective disorder. European Archives of Psychiatry and Clinical Neuroscience, 243, 229–234.
19. Emamghoreishi, M., Schlichter, L., Li, P. P. et al. (1997). High intracellular calcium concentrations in transformed lymphoblasts from subjects with bipolar I disorder. American Journal of Psychiatry, 154, 976–982.
20. Fernandes, B. S., Gama, C. S., Maria Ceresér, K. et al. (2011). Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review mand meta-regression analysis. Journal of Psychiatric Research, (in press).
21. Gigante, A. D., Young, L. T., Yatham, L. N., Andreazza, A. C., Nery, F. G., Grinberg, L. T., Heinsen, H. and Lafer, B., (2010). Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis. International Journal of Neuropsychopharmacology, 23, 1–15.
22. Goes, F. S., Sanders, L. L. and Potash, J. B. (2008). The genetics of psychotic bipolar disorder. Current Psychiatry Reports, 10, 178–189.
23. Grangeon, M. C., Seixas, C., Quarantini, L. C. et al. (2010). White matter hyperintensities and their association with suicidality in major af ective disorders: a meta-analysis of magnetic resonance imaging studies. CNS Spectrum, 15, 375–381.
24. Ha, T. H., Ha, K., Kim, J. H. and Choi, J. E.(2009). Regional brain gray matter abnormalities in patients with bipolar II disorder: a comparison study with bipolar I patients and healthy controls. Neuroscience Letters, 456, 44–48.
25. Hahn, C. G., Gomez, G., Restrepo, D. et al. (2005). Aberrant intracellular calcium signalling in olfactory neurons from patients with bipolar disorder. American Journal of Psychiatry, 162, 616–618.
26. Hajek, T., Bernier, D., Slaney, C. et al. (2008). A comparison of af ected and unaf ected relatives of patients with bipolar disorder using proton magnetic resonance spectroscopy. Journal of Psychiatry Neuroscience, 33, 531–540.
27. Hallahan, B., Newell, J., Soares, J. C. et al. (2011). Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data. Biological Psychiatry, 69, 326–335.
28. Hamakawa, H., Kato, T., Murashita, J. and Kato, N. (1998). Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders. European Archives Psychiatry and Clinical Neuroscience, 248, 53–58.
29. Hamakawa, H., Kato, T., Shioiri, T., Inubushi, T. and Kato, N. (1999). Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorde r. Psychological Medicine, 29, 639–644.
30. Harvaky-Friedman, J. M., Keilp, J. G. et al. (2006). Are bipolar I and bipolar II disorder suicide attempters distinct neuropsychologically? Journal of Affective Disorders, 94, 255–259.
31. Hauser, P., Matochik, J., Altshuler, L. L. et al. (2000). MRI-based measurements of temporal lobe and ventricular structures in patients with bipolar I and bipolar II disorders. Journal of Affective Disorders, 60, 25–32.
32. Hsiao, Y. L., Wu, Y. S., Wu, J. Y. et al. (2009). Neuropsychological functions in patients with bipolar I and bipolar II disorder. Bipolar Disorders, 11, 547–554.
33. Huang, J., Perlis, R. H., Lee, P. H. et al. (2010). Cross-disorder genome-wide analysis of schizophrenia, bipolar disorder, and depression. American Journal of Psychiatry, 167, 1254–1263.
34. Joo, E. J., Lee, K. Y., Jeong, S. H. et al. (2007). Dysbindin gene variants are associated with bipolar I disorder in a Korean population. Neuroscience Letters, 418, 272–275.
35. Kato, T., Takahashi, S., Shioiri, T., Murashita, J., Hamakawa, H. and Inubushi, T. (1994). Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy. Journal of Af ective Disorders, 31, 125–133.
36. Kempton, M. J., Geddes, J. R., Ettinger, U., Williams, S. C. and Grasby, P. M. (2008). Meta-analysis, database, and metaregression of 98 structural imaging studies in bipolar disorder. Archives of General Psychiatry, 65, 1017–1032.
37. Ketter, T. A., Kimbrell, T. A., George, M. S. et al. (2001). Ef ects of mood and subtype on cerebral glucose metabolism in treatmentresistant bipolar disorder. Biological Psychiatry, 49, 97–109.
38. Langdan, C. and McDonald, C. (2009). Neurobiological trait abnormalities in bipolar disorder. Molecular Psychiatry, 14, 833–846.
39. Liu, J. X., Chen, Y. S., Hsieh, J. C., Su, T. P., Yeh, T. C. and Chen, L. F. (2010). Dif erences in white matter abnormalities between bipolar I and II disorders. Journal of Af ective Disorders, 127, 309–315.
40. Mah, L., Zarate, C. A. Jr, Singh, J. et al. (2007). Regional cerebral glucose metabolic abnormalities in bipolar II depression. Biological Psychiatry, 61, 765–775.
41. Mahon, K., Burdick, K. E. and Szeszko, P. R. (2010). A role for white matter abnormalities in the pathophysiology of bipolar disorder. Neuroscience and Biobehavioral Review, 34, 533–554.
42. Martinowich, K., Schloesser, R. J. and Manji, H. K. (2009). Bipolar disorder: from genes to behavior pathways. Journal of Clinical Investigations, 119, 726–736.
43. Michael, N., Erfurth, A. and Pl eiderer, B. (2009). Elevated metabolites within dorsolateral prefrontal cortex in rapid cycling bipolar disorder. Psychiatry Research, 172, 78–81.
44. Monteleone, P., Serritella, C., Martiadis, V. and Maj, M. (2008). Decreased levels of serum brain-derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders. Bipolar Disorders, 10, 95–100.
45. Narita, K., Suda, M., Takei, Y. et al. (2011). Volume reduction of ventromedial prefrontal cortex in bipolar II patients with rapid cycling: a voxel-based morphometric study. Progress in Neuropsychopharmacology and Biological Psychiatry, 35, 439–445.
46. Nwulia, E. A., Miao, K., Zandi, P. P., Mackinnon, D. F., DePaulo, J. R. Jr. and McInnis, M. G. (2007). Genome-wide scan of bipolar II disorder. Bipolar Disorders, 9, 580–588.
47. Pan, L., Keener, M. T., Hassel, S. and Phillips, M. L. (2009). Functional neuroimaging studies of bipolar disorder: examining the wide clinical spectrum in the search for disease endophenotypes. International Review of Psychiatry, 21, 368–379.
48. Pearlson, G. D., Wong, D. F., Tune, L. E. et al. (1995). In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder. Archives of General Psychiatry, 52, 471–477.
49. Perez, J., Tardito, D., Mori, S., Racagni, G., Smeraldi, E. and Zanardi, R. (1999). Abnormalities of cyclic adenosine monophosphate signalling in platelets from untreated patients with bipolar disorder. Archives of General Psychiatry, 56, 248–253.
50. Rajkowska, G., Halaris, A. and Selemon, L. D. (2001). Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biological Psychiatry, 49, 741–752.
51. Serai ni, G., Pompili, M., Innamorati, M. et al. (2010). Deep white matter hyperintensities as possible predictor of poor prognosis in a sample of patients with late-onset bipolar II disorder. Bipolar Disorder, 12, 755–756.
52. Silverstone, P. H. and McGrath, B. M. (2009). Lithium and valproate and their possible effects on themyo-inositol second messenger system in healthy volunteers and bipolar patients. International Review of Psychiatry, 21, 414–423.
53. Simonsen, C., Sundet, K., Vaskinn, A. et al. (2008). Neurocognitive profiles in bipolar I and bipolar II disorder: differences in pattern and magnitude of dysfunction. Bipolar Disorder, 10, 245–255.
54. Suhara, T., Nakayama, K., Inoue, O. et al. (1992). D1 dopamine receptor binding in mood disorders measured by positron emission tomography. Psychopharmacology (Berl.), 106, 14–18.
55. Summers, M., Papadopoulou, K., Bruno, S., Cipolotti, L. and Ron, M. A. (2006). Bipolar I and II disorder: cognition and emotion processing. Psychological Medicine, 36, 1799–1809.
56. Tardito, D., Mori, S., Racagni, G., Smeraldi, E., Zanardi, R. and Perez, J. (2003). Protein kinase activity in platelets from patients with bipolar disorder. Journal of Af ective Disorders, 76, 249–253.
57. Torrent, C., Martinez-Aran, A., Daban, C. et al. (2006). Cognitive impairment in bipolar II disorder. British Journal of Psychiatry, 189, 254–259.
58. Tost, H., Ruf, M., Schmäl, C. et al. (2010). Prefrontal-temporal gray matter dei cits in bipolar disorder patients with persecutory delusions. Journal of Af ective Disorders, 120, 54–61.
59. Uemura, T., Green, M., Corson, T. W., Perova, T., Li, P. P. and Warsh, J. J. (2011). Bcl-2 SNP rs956572 associates with disrupted intracellular calcium homeostasis in bipolar I disorder. Bipolar Disorder, 13, 41–51.
60. Uranova, N., Vostrikov, V. M., Orlovskaya, D. D. and Rachmanova, V. I. (2004). Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: the study from the Stanley Neuropathology Consortium. Schizophrenia Research, 67, 269–275.
61. Vostrikov, V. M., Uranova, N. and Orlovskaya, D. D. (2007). Dei cit of perineuronal\ oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders. Schizophrenia Research, 94, 273–280.
62. Welander-Vatn, A. S., Jensen, J., Lycke, C. et al. (2009). No altered dorsal anterior cingulated activation in bipolar II disorder patients during a Go/No-go task: an fMRI study. Bipolar Disorders, 11, 270–279.
63. Winsberg, M. E., Sachs, N., Tate, D. L., Adalsteinsson, E., Spielman, D. and Ketter, T. A. (2000). Decreased dorsolateral prefrontal N -acetyl aspartate in bipolar disorder. Biological Psychiatry, 47, 475–481.
64. Yildiz-Yesiloglu, A. and Ankerst, D. P. (2006). Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy i ndings. Progress in Neuropsychopharmacology and Biological Psychiatry, 30, 969–995.
65. Yüksel, C. and Öng ür, D. (2010). Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders. Biological Psychiatry, 68, 785–94.
66. Zhang, X., Zhang, Z., Sha, W., Xie, C., Xi, G., Zhou, H. and Zhang, Y. (2010). Ef ect of treatment on serum glial cell line-derived neurotrophic factor in bipolar patients. Journal of Af ective Disorders, 126, 326–329.
67. Zubieta, J. K., Taylor, S. F., Huguelet, P., Koeppe, R. A., Kilbourn, M. R. and Frey, K. A. (2001). Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects. Biological Psychiatry, 49, 110–116.